Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physicians and the pharmaceutical industry: a dysfunctional relationship.

Morris A Fisher1

  • 1Loyola University Stritch School of Medicine, Maywood, IL, USA. morris.fisher@med.va.gov

Perspectives in Biology and Medicine
|May 2, 2003
PubMed
Summary

The pharmaceutical industry prioritizes profit over new drug development, leading to high US drug costs and potential patient harm. Evidence suggests marketing, not R&D, drives expenses, impacting medical ethics and physician judgment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy.

Frontiers in neuroscience·2019
Same author

Recurrence Quantification Analysis of F-Waves and the Evaluation of Neuropathies.

Neurology research international·2015
Same author

F-waves in diabetes mellitus: Answers and questions.

Muscle & nerve·2013
Same author

A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.

Journal of medical case reports·2011
Same author

Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

Journal of clinical neuromuscular disease·2008
Same author

Submaximal stimulation and f-wave parameters.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2008

Area of Science:

  • Pharmaceutical industry economics
  • Medical ethics
  • Drug development and regulation

Background:

  • The pharmaceutical industry is a highly profitable global sector with significant economic influence in the US.
  • US drug costs are exceptionally high compared to other nations.
  • Concerns exist regarding the industry's influence on medicine due to differing priorities.

Purpose of the Study:

  • To critically examine the pharmaceutical industry's focus on profit over meaningful drug development.
  • To investigate the impact of industry practices on medical truth, disclosure, and physician judgment.
  • To highlight issues exemplified by butorphanol (Stadol) and propose systemic changes.

Main Methods:

  • Analysis of the pharmaceutical industry's economic practices and influence.
Keywords:
Health Care and Public Health

Related Experiment Videos

  • Review of evidence regarding drug development costs versus marketing expenditures.
  • Case study analysis of butorphanol (Stadol) to illustrate systemic problems.

    • Main Results:

    • Evidence does not support claims of high drug development expenses; marketing appears prioritized.
    • Industry practices conflict with medical needs for truth and full disclosure.
    • Physician judgment and academic standards may be compromised, leading to adverse drug effects.

    Conclusions:

    • The pharmaceutical industry's profit-driven strategies can harm patients and compromise medical integrity.
    • Government regulation has not fully mitigated unnecessary adverse drug effects.
    • Systemic changes are needed to align the pharmaceutical industry with patient and physician needs.